Novaliq Announces First Patient Randomized in the Phase 3 tria... - 09 December 2020 00:00

HEIDELBERG, Germany, Dec 8 /PRNewswire-AsiaNet/ -- - ESSENCE-2 is the second registration trial to complete the clinical development of CyclASol® as agreed with U.S. Food and Drug Administration (FDA) - Designed to replicate efficacy demonstrated in previous phase 2/3 ESSENCE-1 trial - Topl...

  Abcam reveals new cell engineering facility in Bay Area - 08 December 2020 23:49

CAMBRIDGE, England, Dec. 8, 2020 /PRNewswire-AsiaNet/ -- - State-of-the-art site will enable rapid delivery of engineered cell lines - Powering ready-to-use edited cell-line portfolio expansion - Enable comprehensive customization for research, diagnostic and therapeutic development Today Abcam[h...

  Over 65 speakers across 8 countries address critical themes of... - 08 December 2020 18:02

SYDNEY, Dec. 08 /PRNewswire-AsiaNet/ -- - Resilience for all from the next disaster - What should better preparedness mean after Covid-19 was discussed at two-day event, organised by UNSW, Sydney and SEEDS The vulnerable are most severely impacted as the frequency of naturally-tr...

  PostEra enters a multi-year strategic partnership with Pfizer ... - 08 December 2020 01:49

SAN FRANCISCO, Dec. 8, 2020 /PRNewswire-AsiaNet/ -- PostEra ( https://c212.net/c/link/?t=0&l=en&o=3004173-1&h=522007963&u=https%3A%2F%2Fpostera.ai%2F&a=PostEra ), a biotechnology company specializing in machine learning solutions for preclinical drug discovery, today announced a strategic partnersh...

  INOVIO Doses First Subject in Phase 2 Segment of its INNOVATE ... - 08 December 2020 00:00

PLYMOUTH MEETING, Pa., Dec. 7, 2020 /PRNewswire-AsiaNet/ -- INOVIO (NASDAQ: INO), a biotechnology company focused on bringing to market precisely designed DNA medicines to treat and protect people from infectious diseases and cancer, today announced it has dosed its first subject in a Phase 2 clinical tria...

  Drawbridge Health partners with University of Cambridge Resear... - 04 December 2020 01:00

MENLO PARK, Calif., Dec. 3, 2020 /PRNewswire/ -- Drawbridge Health and the Medical Research Council (MRC) Epidemiology Unit, University of Cambridge (UK) today announced the use of the OneDraw(TM) Blood Collection Device[1] for remote blood sample collection in a large-scale surveillance study c...

  INOVIO Expands Global Manufacturing Consortium For Its COVID-1... - 04 December 2020 00:00

PLYMOUTH MEETING, Pa., Dec. 3, 2020 /PRNewswire-AsiaNet/ -- -- Partnership with leading global plasmid manufacturer advances INOVIO's INO-4800 -- Kaneka Eurogentec to support production of INO-4800 INOVIO (NASDAQ:INO), a biotechnology company focused on bringing to market precisely design...

  Dole Packaged Foods Launches Heartfelt #UnstuffedBears Initiat... - 03 December 2020 15:00

SINGAPORE, Dec. 3, 2020 /PRNewswire-AsiaNet/ -- -- With 1 in 5 children worldwide expected to go hungry this Christmas, Dole continues to activate on "The Dole Promise" with a childhood icon: teddy bears This Christmas, it is estimated that one in five children may go hungry across the globe...

  BD to Invest $1.2 Billion in Pre-Fillable Syringe Manufacturin... - 02 December 2020 23:00

FRANKLIN LAKES, N.J., December 2, 2020 /PRNewswire-AsiaNet/ -- - Investment includes new manufacturing facility in Europe BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced plans to invest approximately $1.2 billion over a 4-year period to expan...

  PixCell Medical to Enhance NSW Health Pathology's Point-of-Car... - 02 December 2020 18:01

YOKNEAM ILIT, Israel, Dec. 2, 2020 /PRNewswire-AsiaNet/ -- - Following TGA approval, NSW Health to Implement PixCell's HemoScreen(TM) Device Across Health System PixCell Medical (https://www.pixcell-medical.com/), innovator of rapid diagnostic solutions at the point-of-care, announced today that NS...